298 related articles for article (PubMed ID: 12750801)
21. Molecular detection and characterization of circulating tumor cells and micrometastases in prostatic, urothelial, and renal cell carcinomas.
Ghossein RA; Bhattacharya S
Semin Surg Oncol; 2001 Jun; 20(4):304-11. PubMed ID: 11747272
[TBL] [Abstract][Full Text] [Related]
22. Molecular diagnostics in urologic malignancies: a work in progress.
Netto GJ
Arch Pathol Lab Med; 2011 May; 135(5):610-21. PubMed ID: 21526959
[TBL] [Abstract][Full Text] [Related]
23. Tumour suppressor genes in urinary tract oncology.
Brewster SF; Gingell JC; Brown KW
Br J Urol; 1992 Dec; 70(6):585-90. PubMed ID: 1336697
[No Abstract] [Full Text] [Related]
24. The role of imaging in the surveillance of urologic malignancies.
Bradford TJ; Montie JE; Hafez KS
Urol Clin North Am; 2006 Aug; 33(3):377-96. PubMed ID: 16829272
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of Urine Aquaporin-1 and Perilipin-2 Concentrations as Biomarkers to Screen for Renal Cell Carcinoma: A Prospective Cohort Study.
Morrissey JJ; Mellnick VM; Luo J; Siegel MJ; Figenshau RS; Bhayani S; Kharasch ED
JAMA Oncol; 2015 May; 1(2):204-12. PubMed ID: 26181025
[TBL] [Abstract][Full Text] [Related]
26. Recurrent TERT promoter mutations in urothelial carcinoma and potential clinical applications.
Kurtis B; Zhuge J; Ojaimi C; Ye F; Cai D; Zhang D; Fallon JT; Zhong M
Ann Diagn Pathol; 2016 Apr; 21():7-11. PubMed ID: 27040924
[TBL] [Abstract][Full Text] [Related]
27. [Prognostic and predictive molecular markers for urologic cancers].
Hartmann A; Schlomm T; Bertz S; Heinzelmann J; Hölters S; Simon R; Stoehr R; Junker K
Urologe A; 2014 Apr; 53(4):491-500. PubMed ID: 24700189
[TBL] [Abstract][Full Text] [Related]
28. TP53 alterations as a potential diagnostic marker in superficial bladder carcinoma and in patients serum, plasma and urine samples.
Dahse R; Utting M; Werner W; Schimmel B; Claussen U; Junker K
Int J Oncol; 2002 Jan; 20(1):107-15. PubMed ID: 11743649
[TBL] [Abstract][Full Text] [Related]
29. [Tumor inhibitory factors in urologic malignancies].
Uemura H
Hinyokika Kiyo; 2008 Jan; 54(1):49-52. PubMed ID: 18260361
[TBL] [Abstract][Full Text] [Related]
30. The molecular signature for urothelial carcinoma of the upper urinary tract.
Ho CL; Tzai TS; Chen JC; Tsai HW; Cheng HL; Eisenberger CF; Chow NH
J Urol; 2008 Mar; 179(3):1155-9. PubMed ID: 18206169
[TBL] [Abstract][Full Text] [Related]
31. Rapid and quantitative detection of human septin family Bradeion as a practical diagnostic method of colorectal and urologic cancers.
Tanaka M; Tanaka T; Matsuzaki S; Seto Y; Matsuda T; Komori K; Itoh J; Kijima H; Tamai K; Shibayama M; Hashimoto Y; Nakazawa H; Toma H
Med Sci Monit; 2003 Jul; 9(7):MT61-8. PubMed ID: 12883458
[TBL] [Abstract][Full Text] [Related]
32. [The diagnostic value of microsatellite LOH analysis and the prognostic relevance of angiogenic gene expression in urinary bladder cancer].
Szarvas T
Magy Onkol; 2009 Dec; 53(4):385-9. PubMed ID: 20071311
[TBL] [Abstract][Full Text] [Related]
33. Urothelial Carcinoma Detection Based on Copy Number Profiles of Urinary Cell-Free DNA by Shallow Whole-Genome Sequencing.
Ge G; Peng D; Guan B; Zhou Y; Gong Y; Shi Y; Hao X; Xu Z; Qi J; Lu H; Zhang X; Zhan Y; Li Y; Wu Y; Ding G; Shen Q; He Q; Li X; Zhou L; Ci W
Clin Chem; 2020 Jan; 66(1):188-198. PubMed ID: 31811000
[TBL] [Abstract][Full Text] [Related]
34. [Urinary cytology of transitional-cell carcinoma].
Piazza G; Galia A; Cosentino A; Grasso G
Pathologica; 1995 Apr; 87(2):146-7. PubMed ID: 8532407
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic and prognostic biomarkers of common urological cancers based on aberrant DNA methylation.
Peng D; Ge G; Xu Z; Ma Q; Shi Y; Zhou Y; Gong Y; Xiong G; Zhang C; He S; He Z; Li X; Ci W; Zhou L
Epigenomics; 2018 Sep; 10(9):1189-1199. PubMed ID: 30182734
[TBL] [Abstract][Full Text] [Related]
36. Applications of spectroscopy in diagnosis, staging, and treatment of urologic malignancies.
Seltz LM; Herrell SD
Curr Opin Urol; 2016 May; 26(3):259-63. PubMed ID: 26914060
[TBL] [Abstract][Full Text] [Related]
37. Detection of let-7 miRNAs in urine supernatant as potential diagnostic approach in non-metastatic clear-cell renal cell carcinoma.
Fedorko M; Juracek J; Stanik M; Svoboda M; Poprach A; Buchler T; Pacik D; Dolezel J; Slaby O
Biochem Med (Zagreb); 2017 Jun; 27(2):411-417. PubMed ID: 28694731
[TBL] [Abstract][Full Text] [Related]
38. Long noncoding RNA in prostate, bladder, and kidney cancer.
Martens-Uzunova ES; Böttcher R; Croce CM; Jenster G; Visakorpi T; Calin GA
Eur Urol; 2014 Jun; 65(6):1140-51. PubMed ID: 24373479
[TBL] [Abstract][Full Text] [Related]
39. Long Noncoding RNAs as Innovative Urinary Diagnostic Biomarkers.
Brisotto G; Guerrieri R; Colizzi F; Steffan A; Montico B; Fratta E
Methods Mol Biol; 2021; 2292():73-94. PubMed ID: 33651353
[TBL] [Abstract][Full Text] [Related]
40. Molecular differential diagnosis of renal cell carcinomas by microsatellite analysis.
Bugert P; Kovacs G
Am J Pathol; 1996 Dec; 149(6):2081-8. PubMed ID: 8952540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
